Filing step-change
AMRAPLIN · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
Here is the standard_shift narrative based on the provided payload: The Indian equity market experienced a 0.11% gross margin, flat from the previous quarter, with no significant changes in the company's profitability.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| MARGINAL_OPERATING_LEVERAGE | 0.11 % | 0.03 | ▲ |
| REVENUE_GROWTH_YOY | 78.3 % | 928.6 | ▼ |
Cite this
Source: Samhati filing step-change for AMRAPLIN (2026-09). Observation: Here is the standard_shift narrative based on the provided payload: The Indian equity market experienced a 0.11% gross margin, flat from the previous quarter, with no significant changes in the company's profitability. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/amraplin/q/2026-09
Other periods